🛑🛑🛑 The U.S. Food and Drug Administration (FDA) has issued a warning to veterinarians regarding serious complications associated with LIBRELA, a monoclonal antibody injection used to manage osteoarthritis pain in dogs. Since its U.S. approval in May 2023, LIBRELA has been linked to adverse events including seizures, urinary incontinence, paralysis,